Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Biweekly paclitaxel and cisplatin in patients with advanced head and neck carcinoma. A phase II trialL Licitra, G Capri, F Fulfaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patientsL Licitra, R Cavina, C Grandi, et al.
International Journal of Cancer|December 8, 1998
Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancersA Costa, L Licitra, S Veneroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II studyH Soto Parra, R Cavina, F Latteri, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2021
Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancerCiro Franzese, M Badalamenti, A Teriaca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancerL Licitra, L D Locati, R Cavina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancerA Santoro, R Cavina, F Latteri, et al.
Pageof 2